Coventry University Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
University of Sheffield Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Sheffield Featured PhD Programmes
"pharmacology"×
10 miles

Cancer / Oncology (pharmacology) PhD Projects, Programs & Scholarships

We have 16 Cancer / Oncology (pharmacology) PhD Projects, Programs & Scholarships

  • "pharmacology" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 15 of 16
  Probing Conformational Change in Protein Kinases Using Single Molecule Fluorescence Spectroscopy and Unnatural Amino Acids
  Dr C Dodson, Dr I M Eggleston
Applications accepted all year round

Funding Type

PhD Type

This project will be a collaboration between Dr Charlotte Dodson (lead), Department of Pharmacy & Pharmacology, University of Bath;.
  Neuropeptide Research - PhD Opportunity at a World Class Institution
  Dr M Muttenthaler, Assoc Prof C Schroeder, Assoc Prof I Vetter
Applications accepted all year round

Funding Type

PhD Type

We are seeking talented and highly motivated PhD candidates for the following multidisciplinary project. Neuropeptides are key mediators in many biological functions and understanding their interaction with target proteins is fundamental to unravel the underlying mechanism of diseases.
  Targeting ageing: Genes and compounds with pro-longevity, health-preserving effects
  Dr JP de Magalhaes
Applications accepted all year round

Funding Type

PhD Type

Ageing is arguably the major biomedical challenge of the 21st century. In model organisms, the process of ageing can be manipulated by both genetic manipulations and dietary interventions.
  Targeting the Gas6-TAM receptor signalling pathway in cancer
  Dr S Hafizi
Applications accepted all year round

Funding Type

PhD Type

Applications are invited for a self-funded 3 year full-time PhD project, to commence in October 2019 or February 2020. The PhD will be based in the School of Pharmacy and Biomedical Sciences and will be supervised by Dr Sassan Hafizi.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  London Interdisciplinary Biosciences Consortium (LIDo)

Funding Type

PhD Type

 LIDo is an exciting collaboration between UCL, Kings College London, Queen Mary, Birkbeck, Royal Veterinary College and London School of Hygiene and Tropical Medicine, six of London's world-class universities and specialist institutions.
  Design, synthesis and evaluation of novel polysialyltransferase inhibitors as anti- metastatic agents
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Dr S Shnyder
Applications accepted all year round

Funding Type

PhD Type

Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases (polySTs).
  Design, synthesis and evaluation of protease-activated anti-cancer prodrugs
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Prof P Loadman
Applications accepted all year round

Funding Type

PhD Type

Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis.
  Polysialyltransferases as a target in metastatic cancer
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Dr S Shnyder
Applications accepted all year round

Funding Type

PhD Type

Polysialic acid plays an essential role in neuronal development, but by adulthood is absent from the human body. Its biosynthesis is regulated by two polysialyltransferases.
  Therapeutic resolution of Myodysplastic Syndrome (MDS)
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

Myelodysplastic syndromes (MDS) are the most common adult myeloid malignancy in the UK and it has been estimated that around 8,000 and 40,000 new cases are diagnosed each year in the UK and USA, respectively.
  Mechanisms of Cancer Stem Cell Survival, Metastasis Formation and Immune Evasion in Cancer
  Dr D Widera
Applications accepted all year round

Funding Type

PhD Type

Recent research suggests that cancer cells within a tumour represent a highly heterogeneous cell population. In particular many tumours contain small percentage of cells that share several characteristics with stem cells.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.